Compass Pathways Plc (CMPS)
$8.42
Insights on Compass Pathways Plc
Vs DVA
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 66.9%
Vs THC
In the last 3 years, Tenet Healthcare Corp. has given 12.8% return, outperforming this stock by 88.0%
Performance
- $8.31$8.69$8.42
1.29%
Downside
Day's Volatility :4.36%
Upside
3.11%
- $5.01$12.75$8.42
40.5%
Downside
52 Weeks Volatility :60.71%
Upside
33.96%
Returns
| Period | Compass Pathways Plc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 4.92% | -0.7% | 0.0% |
6 Months | 39.84% | 6.6% | 0.0% |
1 Year | -14.01% | 3.7% | -1.5% |
3 Years | -75.16% | 14.0% | -21.8% |
Highlights
Market Capitalization | 583.0M |
Book Value | $3.64 |
Earnings Per Share (EPS) | -2.32 |
Wall Street Target Price | 41.25 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -32.76% |
Return On Equity TTM | -58.21% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -123.8M |
Diluted Eps TTM | -2.32 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.29 |
EPS Estimate Next Year | -2.19 |
EPS Estimate Current Quarter | -0.33 |
EPS Estimate Next Quarter | -0.59 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 389.9%
Technicals Summary
Sell
Neutral
Buy
Compass Pathways Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Compass Pathways Plc | -12.87% | 39.84% | -14.01% | -75.16% | -70.59% |
 Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
 Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
 Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
 Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
 Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Compass Pathways Plc | NA | NA | NA | -2.29 | -0.58 | -0.33 | NA | 3.64 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Compass Pathways Plc | Buy | $583.0M | -70.59% | NA | 0.0% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
Institutional Holdings
TCG Crossover Management, LLC
6.01%ARK Investment Management LLC
4.08%Paradigm Biocapital Advisors LP
3.53%Vivo Capital, LLC
2.50%Citadel Advisors Llc
2.44%RA Capital Management, LLC
2.00%
Corporate Announcements
Compass Pathways Plc Earnings
Compass Pathways Plc’s price-to-earnings ratio stands at None
Read More
Company Information
compass pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. our first major initiative is developing psilocybin therapy through late-stage clinical trials in the eu and us for patients with treatment-resistant depression. we are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
Organization | Compass Pathways Plc |
Employees | 186 |
CEO | Mr. Kabir Nath M.A., M.B.A. |
Industry | Finance |
